Sally J Vansweden, MD | |
601 John St, Box 74 - Bronson Internal Medicine Specialist, Kalamazoo, MI 49007-5341 | |
(269) 341-8481 | |
(269) 341-7781 |
Full Name | Sally J Vansweden |
---|---|
Gender | Female |
Speciality | Pediatric Medicine |
Experience | 27 Years |
Location | 601 John St, Kalamazoo, Michigan |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053394551 | NPI | - | NPPES |
CA2184 | Other | MI | RAILROAD MEDICARE |
1053394551 | Medicaid | MI | |
4315939 | Medicaid | MI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 4301069810 (Michigan) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Bronson Methodist Hospital | Kalamazoo, MI | Hospital |
Bronson Battle Creek Hospital | Battle creek, MI | Hospital |
Bronson South Haven Hospital | South haven, MI | Hospital |
Bronson Lakeview Hospital | Paw paw, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Bronson Methodist Hospital | 0244148633 | 598 |
News Archive
An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds.
Following a report of a UK case of liver failure suspected to be associated with an unlicensed traditional Chinese medicine (TCM), the MHRA has discovered the illegal and dangerous inclusion of nitrosofenfluramine and fenfluramine, in Shubao Slimming Capsules being supplied on the UK market.
Zafgen, a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced positive topline results from its Phase 1b study of ZGN-433, a methionine aminopeptidase 2 inhibitor, for the treatment of severe obesity.
The Wall Street Journal reports that following President Barack Obama's re-election, health stocks are viewed as a port in the storm. Other news outlets explore how the markets have remained stable during the 'fiscal cliff' negotiations as investors count on an eleventh-hour deal.
› Verified 1 days ago
Entity Name | Bronson Methodist Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417961137 PECOS PAC ID: 0244148633 Enrollment ID: O20031208000832 |
News Archive
An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds.
Following a report of a UK case of liver failure suspected to be associated with an unlicensed traditional Chinese medicine (TCM), the MHRA has discovered the illegal and dangerous inclusion of nitrosofenfluramine and fenfluramine, in Shubao Slimming Capsules being supplied on the UK market.
Zafgen, a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced positive topline results from its Phase 1b study of ZGN-433, a methionine aminopeptidase 2 inhibitor, for the treatment of severe obesity.
The Wall Street Journal reports that following President Barack Obama's re-election, health stocks are viewed as a port in the storm. Other news outlets explore how the markets have remained stable during the 'fiscal cliff' negotiations as investors count on an eleventh-hour deal.
› Verified 1 days ago
Entity Name | Family Health Center, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1811065576 PECOS PAC ID: 1759370216 Enrollment ID: O20040510000899 |
News Archive
An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds.
Following a report of a UK case of liver failure suspected to be associated with an unlicensed traditional Chinese medicine (TCM), the MHRA has discovered the illegal and dangerous inclusion of nitrosofenfluramine and fenfluramine, in Shubao Slimming Capsules being supplied on the UK market.
Zafgen, a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced positive topline results from its Phase 1b study of ZGN-433, a methionine aminopeptidase 2 inhibitor, for the treatment of severe obesity.
The Wall Street Journal reports that following President Barack Obama's re-election, health stocks are viewed as a port in the storm. Other news outlets explore how the markets have remained stable during the 'fiscal cliff' negotiations as investors count on an eleventh-hour deal.
› Verified 1 days ago
Entity Name | Bronson Lakeview Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235131137 PECOS PAC ID: 9032008495 Enrollment ID: O20051027001022 |
News Archive
An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds.
Following a report of a UK case of liver failure suspected to be associated with an unlicensed traditional Chinese medicine (TCM), the MHRA has discovered the illegal and dangerous inclusion of nitrosofenfluramine and fenfluramine, in Shubao Slimming Capsules being supplied on the UK market.
Zafgen, a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced positive topline results from its Phase 1b study of ZGN-433, a methionine aminopeptidase 2 inhibitor, for the treatment of severe obesity.
The Wall Street Journal reports that following President Barack Obama's re-election, health stocks are viewed as a port in the storm. Other news outlets explore how the markets have remained stable during the 'fiscal cliff' negotiations as investors count on an eleventh-hour deal.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Sally J Vansweden, MD 601 John St, Box 42, Kalamazoo, MI 49007-5341 Ph: (269) 341-8481 | Sally J Vansweden, MD 601 John St, Box 74 - Bronson Internal Medicine Specialist, Kalamazoo, MI 49007-5341 Ph: (269) 341-8481 |
News Archive
An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds.
Following a report of a UK case of liver failure suspected to be associated with an unlicensed traditional Chinese medicine (TCM), the MHRA has discovered the illegal and dangerous inclusion of nitrosofenfluramine and fenfluramine, in Shubao Slimming Capsules being supplied on the UK market.
Zafgen, a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced positive topline results from its Phase 1b study of ZGN-433, a methionine aminopeptidase 2 inhibitor, for the treatment of severe obesity.
The Wall Street Journal reports that following President Barack Obama's re-election, health stocks are viewed as a port in the storm. Other news outlets explore how the markets have remained stable during the 'fiscal cliff' negotiations as investors count on an eleventh-hour deal.
› Verified 1 days ago
Dr. Eric S Shay, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 John St, Suite M-170, Kalamazoo, MI 49007 Phone: 269-381-5060 Fax: 269-381-1655 | |
Michael Trexler, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1521 Gull Rd, Suite 173, Kalamazoo, MI 49048 Phone: 269-226-5165 | |
Dr. Christopher Rogers, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 John St, Ste 100, Kalamazoo, MI 49007 Phone: 269-373-1222 Fax: 269-373-6270 | |
Desmonda Brady Wixson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4613 W Main St Ste A, Kalamazoo, MI 49006 Phone: 269-488-8672 Fax: 269-488-8673 | |
Dr. Kevin L. Beyer, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1535 Gull Rd, Suite 105, Kalamazoo, MI 49048 Phone: 269-385-9900 Fax: 269-385-2140 | |
Ernest Lee Yoder, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Oakland Dr, Kalamazoo, MI 49008 Phone: 269-337-6300 | |
Valerie Siqueira Duhn, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 521 E. Michigan Ave, Ste 201, Kalamazoo, MI 49007 Phone: 269-349-6759 Fax: 369-349-7450 |